參考文獻 |
[1]陳耀寬, 李至春, 溫淑緣, 王添泉。2019。煙醯胺單核甘酸輔酶激活素之微粒。中華民國發明專利第M590054號。
[2] Bogan, K.L., Brenner, C. Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition. Annu. Rev. Nutr. 28 (2008): 115–30.
[3] Mills, K.F., Yoshida, S., Stein, L.R., Grozio, A., Kubota, S., Sasaki, Y., Redpath, P., Migaud, M.E., Apte, R.S., Uchida, K., Yoshino, J., Imai, S. Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice. Cell Metab. 24 (2016): 795–806.
[4] Yoshino, J., Mills,K.F., Yoon,M.J., Imai,S.I. Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Diet- and Age-Induced Diabetes in Mice. Cell Metab. 14(2011):528–536.
[5] Liana,R.S., Imai,S.I. Specific ablation of Nampt in adult neural stem cells recapitulates their functional defects during aging. Embo. J. 33(2014):1321-1340.
[6] Fletcher, R.S., Lavery, G.G. The emergence of the nicotinamide riboside kinases in the regulation of NAD+ metabolism. J. Mol. Endocrinol. 61 (2018): R107–R121.
[7] Cambronne, X.A., Kraus, W.L. Location, Location, Location: Compartmentalization of NAD+ Synthesis and Functions in Mammalian Cells. Trends. Biochem. Sci. 45 (2020): 858–873.
[8] Berger, F., Ramirez-Hernandez, M.H., Ziegler, M. The new life of a centenarian: signalling functions of NAD(P). Trends Biochem. Sci. 29(2004):111–118.
[9] Belenky, P., Bogan, K.L., Brenner, C. NAD+ metabolism in health and disease. Trends Biochem. Sci 32(2007):12–19.
[10] Houtkooper, R.H., Canto, C., Wanders, R.J., Auwerx J The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways. Endocr Rev 31(2010):194–223.
[11] Imai, S., Guarente, L. NAD+ and sirtuins in aging and disease. Trends. Cell Bio. 24(2014):464–471.
[12] Owens, K., Park, J.H., Schuh, R., Kristian, T. Mitochondrial dysfunction and NAD+ metabolism alterations in the pathophysiology of acute brain injury. Transl. Stroke Res. 4(2013):618–634.
[13] Klimova, N., Long, A., Kristian, T. Significance of mitochondrial protein post-translational modifications in pathophysiology of brain injury. Transl. Stroke Res. 9(2018):223–237.
[14] Klimova, N., Kristian, T. Multi-targeted Effect of Nicotinamide Mononucleotide on Brain Bioenergetic Metabolism. Neurochem. Res. 44(2019):2280-2287.
[15] Venter, G., Oerlemans, F.T.J.J., Willemse, M., Wijers, M., Fransen, J.A.M., Wieringa, B. NAMPT-Mediated Salvage Synthesis of NAD+ Controls Morphofunctional Changes of Macrophages. Plos. One. 9 (2014): e97378.
[16] Bogan, K.L., Brenner, C. Nicotinic Acid, Nicotinamide, and Nicotinamide Riboside: A Molecular Evaluation of NAD+ Precursor Vitamins in Human Nutrition. Annu. Rev. Nutr. 28(2008):115–130.
[17] Eppig, J.T., Bult, C.J., Kadin, J.A., Richardson, J.E., Blake, J.A., Anagnostopoulos, A., Baldarelli, R.M., Baya, M., Beal, J.S., Bello, S.M. The Mouse Genome Database (MGD): From genes to mice— A community resource for mouse biology. Nucleic. Acids Res. 33(2005):D471–D475.
[18] Marinescu, G.C., Popescu, R.-G., Dinischiotu, A. Size Exclusion Chromatography Method for Purification of Nicotinamide Mononucleotide (NMN) from Bacterial Cells. Sci. Rep. 8(2018):4433.
[19] Sorci, L., Martynowski, D., Rodionov, D.A., Eyobo, Y., Zogaj, X., Klose, K.E., Nikolaev, E.V., Magni, G., Zhang, H., Osterman, A.L. Nicotinamide mononucleotide synthetase is the key enzyme for an alternative route of NAD biosynthesis in Francisella tularensis. Proc. Natl. Acad. Sci. 106(2009):3083–3088.
[20] Poddar, S.K., Sifat, A.E., Haque, S., Nahid, N.A., Chowdhury, S., Mehedi, I. Nicotinamide Mononucleotide: Exploration of Diverse Therapeutic Applications of a Potential Molecule. Biomolecules 9(2019):1-15.
[21] Preiss, J., Handler, P. Enzymatic synthesis of nicotinamide mononucleotide. J. Biol. Chem. (1957):759–770.
[22] Sauve, A., Mohammad, F.S., Heights, J. Efficient synthesis of nicotinamide mononucleotide. 2020. United States Patent No.US010590160B2.
[23] Fukamizu, Y., Tasaki, K., Tateyama,R. 2017. 含高含量之β-NMN的酵母萃取物。中華民國發明專利第201742924號。
[24] Shoji, S., Yamaji, T., Makino, H., Ishii, J., Kondo, A. Metabolic design for selective production of nicotinamide mononucleotide from glucose and nicotinamide. Metab. Eng. 18(2020):1–11.
[25] Marinescu, G.C., Popescu, R.G., Stoian, G., Dinischiotu,A. β-nicotinamide mononucleotide (NMN) production in Escherichia coli. Sci. Rep-UK. 8 (2018):12278.
[26] Zoukhri, D. Effect of inflammation on lacrimal gland function. Exp. Eye Res. 2006, 82, 885–898.
[27] Aredo, B., Zhang, K., Chen, X., Wang, C., Li, T., Ufret-Vincenty, R.L. Differences in the distribution, phenotype and gene expression of subretinal microglia/macrophages in C57BL/6N (Crb1rd8/rd8) versus C57BL6/J (Crb1wt/wt) mice. J. Neuroinflamm. 12(2015):19-23.
[28] Bertoldo, M.J., Listijono, D.R., Ho, W.H.J., Riepsamen, A.H., Goss, D.M., Richani, D., Jin, X.L., Mahbub, S., Campbell, J.M., Habibalahi, A., Loh, W.G.N., Youngson, N.A., Maniam, J., Wong, A.S.A., Selesniemi, K., Bustamante, S., Li, C., Zhao, Y.Q., Marinova, M.B., Kim, L.J., Lau, L., Wu, R.M., Mikolaizak, A.S., Araki, T., Le Couteur, D.G., Turner, N., Morris, M.J., Walters, K.A., Goldys, E., O′Neill, C., Gilchrist, R.B., Sinclair, D.A., Homer, H.A., Wu, L.E. NAD+ Repletion Rescues Female Fertility during Reproductive Aging. Cell Rep. 30 (2020): 1670–1689.
[29] Park, J.H., Long, A., Owens, K., Kristian, T. Nicotinamide mononucleotide inhibits post-ischemic NAD+ degradation and dramatically ameliorates brain damage following global cerebral ischemia. Neurobiol. Dis. 95(2016):102-110.
[30] Tarantini, S., Valcarcel-Ares, M.N., Toth, P., Yabluchanskiy, A. Tucsek, Z., Kiss, T., Hertelendy, P., Kinter, M., Ballabh, P., Süle, Z., Farkas, E., Baur, J.A., Sinclair, D.A., Csiszar, A., Ungvari, Z. Nicotinamide mononucleotide (NMN) supplementation rescues cerebromicrovascular endothelial function and neurovascular coupling responses and improves cognitive function in aged mice. Redox. Bio. 24(2019):101192.
[31] Liang, H., Gao, J., Zhang, C., Li, C., Wang, Q., Fan, J., Wu, Z., Wang, Q. Nicotinamide mononucleotide alleviates Aluminum induced bone loss by inhibiting the TXNIP-NLRP3 inflammasome. Toxicol. Appl. Pharm. 362(2019):20-27.
[32] Revollo, J.R., Korner. A., Mills, K.F., Satoh, A., Wang, T., Garten, A. Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab. 6(2007):363–75
[33] Yang, S. J., Choi, J. M., Kim, L., Park, S. E., Rhee, E. J., Lee, W. Y., Oh, K. W., Park, S. W., Park, C. Y.. Nicotinamide improves glucose metabolism and affects the hepatic NAD-sirtuin pathway in a rodent model of obesity and type 2 diabetes. J. Nutr. Biochem. 25(2014):66-72.
[34] 陳敏恆, 叢德滋, 方Fig. 南等。《化工原理(下冊)(第四版)》. 化學工業出版社。p153。
[35] Ganzler, K., Salgo, A., Valko, K. Microwave extraction. A novel sample preparation method for chromatography. J. Chromatogr. A. 371(1986):299-306.
[36]楊義芳,孔德云(2010)。中藥提取分離新技術。北京:化工工業出版社。
[37] Pan, X., Niu, G., Liu, H. Microwave-assisted extraction of tea polyphenols and tea caffeine from green tea leaves. Chem. Eng. Process. 42(2003):129-133.
[38] Hong, N., Yaylayan, V.A., Raghavan, G.S., Pare, J.R., Belanger, J.M. Microwave-assisted extraction of phenolic compounds from grape seed. Nat. Prod. Lett. 15(2001):197-204.
[39]許海燕。固定多糖苷提取物及其前體脂體的研究。上海:上海醫藥工業研究院。(2006)。
[40]張珩,楊藝虹。綠色製藥技術。北京:化學工業出版社。(2006):194-200。
[41]韓麗。實用中藥製劑新技術。北京:化學工業出版社。(2002):142-147。
[42]劉建文,賈偉。中草藥成分超聲提取。西北大學學報(自然科學網路版)。(2005):70-76。
[43]郭孝武。超聲技術在提取中藥鹼類成分中的應用。世界科學技術-中藥現代化。4(2002):59-63。
[44]徐春龍,林書玉。超聲提取中草藥成分研究進展。藥物分析雜誌。27(2007):933-937。
[45]張曉東,潘國風,呂圭源。超聲提取在中藥化學成分提取中的應用研究進展。時珍國醫國藥。15(2004):861-862。
[46]董嘉德。超聲技術在中藥提取中的應用。傳統醫藥。11(2002):55-56。
[47]劉元。二氧化碳超臨界流體萃取概述。化工之友。12(2006):56-58。
[48]王國義。超臨界流體萃取技術及其應用。技術討論。9(2006):32-34。
[49]張子欽。掃描式電子顯微鏡原理與應用。碧威股份有限公司。
[50]羅聖全。科學基礎研究之重要利器-掃描式電子顯微鏡(SEM)。工業技術研究院奈米科技網。
[51] H. P. Myers. Introductory Solid State Physics. Taylor & Francis. 2002.
[52] 新國科技應用工程師。淺談FTIR分析技術。SCINCO Co., ltd. http://www.scinco.tw/support/technical_01.asp。
[53]國立台灣大學化學系有機教研小組,大學有機化學實驗,第七版,國立台灣大學出版中心:台北市,2004。
[54] Pavia, D. L; Lampman, G. M.; Kriz, G. S. Introduction to Organic Laboratory Techniques: a Contemporary Approach; Saunders College Publishing: New York, 1976.
[55] Shugar, G. J., Shugar, R. A., Bauman, L.; Bauman, R. S. Chemical Technicians’ Ready Reference Handbook; 2nd. ed.; McGraw-Hill Book Co.: New York, 1981.
[56] NMN – NICOTINAMIDE MONONUCLEOTIDE (5 GRAMS) – SUBLINGUAL POWDER. Vital Health Supplements. https://vitalhealthsupplements.com/product/nmn-nicotinamide-mononucleotide-5-grams-sublingual-powder/.
[57] Kemmer, G., Reilly, T.J., Schmidt-Brauns, j., Zlotnik, G.W., GREEN, B. A., FISKE, M.J., Herbert, M., Kraib, A. Schlor, S., Smith, A., Reidl, J. NadN and e (P4) Are Essential for Utilization of NAD and Nicotinamide Mononucleotide but Not Nicotinamide Riboside in Haemophilus influenza. J. Bacteriol. 183(2001):3974-3981. |